Glutamine synthetase (GS) has been established as a useful immunohistological adjunct in the diagnostic procedure of hepatocellular adenoma (HCA) harboring CTNNB1 mutations, being more sensitive than b-catenin immunohistochemistry (IHC), to identify this subtype of HCA. Here, GLUL is linked to hepatocellular adenoma.